You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Devices & Consumables

Global Bio-Implants Market Research Report 2021 Professional Edition

Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patientÆ’ s body.
Market Analysis and Insights: Global Bio-Implants Market
The global Bio-Implants market size is projected to reach US$ 79980 million by 2027, from US$ 60450 million in 2020, at a CAGR of 4.8% during 2021-2027.
Global Bio-Implants Scope and Segment
The global Bio-Implants market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bio-Implants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Allograft
Autograft
Xenograft
By the end users/application, this report covers the following segments
Cardiovascular Implants
Spinal Implants
Orthopedics & Trauma
Dental
Others
Competitive Landscape:
The report provides a list of all the key players in the Bio-Implants market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Bio-Implants key manufacturers in this market include:
AAP Implantate
Abbott Laboratories
Bausch and Lomb Incorporated
Biomet
Biotronik Se & Co.Kg
Boston Scientific Corporation
Cook Group
C.R. Bard
Edwards Lifesciences Corporation
Endo Health Solutions
Johnson & Johnson
Integra Lifesciences Holdings Corporation
Integrated Orbital Implants
Lifenet Health
Medtro
Mimedx Group
Orthofix International
Smith & Nephew
Sorin
Abbott
1 Bio-Implants Market Overview
1.1 Bio-Implants Product Overview
1.2 Bio-Implants Market Segment by Type
1.2.1 Allograft
1.2.2 Autograft
1.2.3 Xenograft
1.3 Global Bio-Implants Market Size by Type
1.3.1 Global Bio-Implants Market Size Overview by Type (2016-2027)
1.3.2 Global Bio-Implants Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Bio-Implants Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Bio-Implants Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Bio-Implants Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Bio-Implants Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Bio-Implants Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Bio-Implants Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Bio-Implants Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bio-Implants Sales Breakdown by Type (2016-2021)
1.4.2 Europe Bio-Implants Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Bio-Implants Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Bio-Implants Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Bio-Implants Sales Breakdown by Type (2016-2021)

2 Global Bio-Implants Market Competition by Company
2.1 Global Top Players by Bio-Implants Sales (2016-2021)
2.2 Global Top Players by Bio-Implants Revenue (2016-2021)
2.3 Global Top Players Bio-Implants Price (2016-2021)
2.4 Global Top Manufacturers Bio-Implants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bio-Implants Market Competitive Situation and Trends
2.5.1 Bio-Implants Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Bio-Implants Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-Implants as of 2020)
2.7 Date of Key Manufacturers Enter into Bio-Implants Market
2.8 Key Manufacturers Bio-Implants Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Bio-Implants Status and Outlook by Region
3.1 Global Bio-Implants Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Bio-Implants Historic Market Size by Region
3.2.1 Global Bio-Implants Sales in Volume by Region (2016-2021)
3.2.2 Global Bio-Implants Sales in Value by Region (2016-2021)
3.2.3 Global Bio-Implants Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Bio-Implants Forecasted Market Size by Region
3.3.1 Global Bio-Implants Sales in Volume by Region (2022-2027)
3.3.2 Global Bio-Implants Sales in Value by Region (2022-2027)
3.3.3 Global Bio-Implants Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Bio-Implants by Application
4.1 Bio-Implants Market Segment by Application
4.1.1 Cardiovascular Implants
4.1.2 Spinal Implants
4.1.3 Orthopedics & Trauma
4.1.4 Dental
4.1.5 Others
4.2 Global Bio-Implants Market Size by Application
4.2.1 Global Bio-Implants Market Size Overview by Application (2016-2027)
4.2.2 Global Bio-Implants Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Bio-Implants Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Bio-Implants Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Bio-Implants Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Bio-Implants Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Bio-Implants Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Bio-Implants Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Bio-Implants Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bio-Implants Sales Breakdown by Application (2016-2021)
4.3.2 Europe Bio-Implants Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Bio-Implants Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Bio-Implants Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Bio-Implants Sales Breakdown by Application (2016-2021)

5 North America Bio-Implants by Country
5.1 North America Bio-Implants Historic Market Size by Country
5.1.1 North America Bio-Implants Sales in Volume by Country (2016-2021)
5.1.2 North America Bio-Implants Sales in Value by Country (2016-2021)
5.2 North America Bio-Implants Forecasted Market Size by Country
5.2.1 North America Bio-Implants Sales in Volume by Country (2022-2027)
5.2.2 North America Bio-Implants Sales in Value by Country (2022-2027)

6 Europe Bio-Implants by Country
6.1 Europe Bio-Implants Historic Market Size by Country
6.1.1 Europe Bio-Implants Sales in Volume by Country (2016-2021)
6.1.2 Europe Bio-Implants Sales in Value by Country (2016-2021)
6.2 Europe Bio-Implants Forecasted Market Size by Country
6.2.1 Europe Bio-Implants Sales in Volume by Country (2022-2027)
6.2.2 Europe Bio-Implants Sales in Value by Country (2022-2027)

7 Asia-Pacific Bio-Implants by Region
7.1 Asia-Pacific Bio-Implants Historic Market Size by Region
7.1.1 Asia-Pacific Bio-Implants Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Bio-Implants Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Bio-Implants Forecasted Market Size by Region
7.2.1 Asia-Pacific Bio-Implants Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Bio-Implants Sales in Value by Region (2022-2027)

8 Latin America Bio-Implants by Country
8.1 Latin America Bio-Implants Historic Market Size by Country
8.1.1 Latin America Bio-Implants Sales in Volume by Country (2016-2021)
8.1.2 Latin America Bio-Implants Sales in Value by Country (2016-2021)
8.2 Latin America Bio-Implants Forecasted Market Size by Country
8.2.1 Latin America Bio-Implants Sales in Volume by Country (2022-2027)
8.2.2 Latin America Bio-Implants Sales in Value by Country (2022-2027)

9 Middle East and Africa Bio-Implants by Country
9.1 Middle East and Africa Bio-Implants Historic Market Size by Country
9.1.1 Middle East and Africa Bio-Implants Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Bio-Implants Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Bio-Implants Forecasted Market Size by Country
9.2.1 Middle East and Africa Bio-Implants Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Bio-Implants Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Bio-Implants Business
10.1 AAP Implantate
10.1.1 AAP Implantate Corporation Information
10.1.2 AAP Implantate Introduction and Business Overview
10.1.3 AAP Implantate Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.1.4 AAP Implantate Bio-Implants Products Offered
10.1.5 AAP Implantate Recent Development
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Corporation Information
10.2.2 Abbott Laboratories Introduction and Business Overview
10.2.3 Abbott Laboratories Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.2.4 AAP Implantate Bio-Implants Products Offered
10.2.5 Abbott Laboratories Recent Development
10.3 Bausch and Lomb Incorporated
10.3.1 Bausch and Lomb Incorporated Corporation Information
10.3.2 Bausch and Lomb Incorporated Introduction and Business Overview
10.3.3 Bausch and Lomb Incorporated Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Bausch and Lomb Incorporated Bio-Implants Products Offered
10.3.5 Bausch and Lomb Incorporated Recent Development
10.4 Biomet
10.4.1 Biomet Corporation Information
10.4.2 Biomet Introduction and Business Overview
10.4.3 Biomet Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Biomet Bio-Implants Products Offered
10.4.5 Biomet Recent Development
10.5 Biotronik Se & Co.Kg
10.5.1 Biotronik Se & Co.Kg Corporation Information
10.5.2 Biotronik Se & Co.Kg Introduction and Business Overview
10.5.3 Biotronik Se & Co.Kg Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Biotronik Se & Co.Kg Bio-Implants Products Offered
10.5.5 Biotronik Se & Co.Kg Recent Development
10.6 Boston Scientific Corporation
10.6.1 Boston Scientific Corporation Corporation Information
10.6.2 Boston Scientific Corporation Introduction and Business Overview
10.6.3 Boston Scientific Corporation Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Boston Scientific Corporation Bio-Implants Products Offered
10.6.5 Boston Scientific Corporation Recent Development
10.7 Cook Group
10.7.1 Cook Group Corporation Information
10.7.2 Cook Group Introduction and Business Overview
10.7.3 Cook Group Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Cook Group Bio-Implants Products Offered
10.7.5 Cook Group Recent Development
10.8 C.R. Bard
10.8.1 C.R. Bard Corporation Information
10.8.2 C.R. Bard Introduction and Business Overview
10.8.3 C.R. Bard Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.8.4 C.R. Bard Bio-Implants Products Offered
10.8.5 C.R. Bard Recent Development
10.9 Edwards Lifesciences Corporation
10.9.1 Edwards Lifesciences Corporation Corporation Information
10.9.2 Edwards Lifesciences Corporation Introduction and Business Overview
10.9.3 Edwards Lifesciences Corporation Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Edwards Lifesciences Corporation Bio-Implants Products Offered
10.9.5 Edwards Lifesciences Corporation Recent Development
10.10 Endo Health Solutions
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Bio-Implants Product Category, Application and Specification
10.10.3 Endo Health Solutions Bio-Implants Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Endo Health Solutions Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Corporation Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Johnson & Johnson Bio-Implants Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 Integra Lifesciences Holdings Corporation
10.12.1 Integra Lifesciences Holdings Corporation Corporation Information
10.12.2 Integra Lifesciences Holdings Corporation Introduction and Business Overview
10.12.3 Integra Lifesciences Holdings Corporation Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Integra Lifesciences Holdings Corporation Bio-Implants Products Offered
10.12.5 Integra Lifesciences Holdings Corporation Recent Development
10.13 Integrated Orbital Implants
10.13.1 Integrated Orbital Implants Corporation Information
10.13.2 Integrated Orbital Implants Introduction and Business Overview
10.13.3 Integrated Orbital Implants Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Integrated Orbital Implants Bio-Implants Products Offered
10.13.5 Integrated Orbital Implants Recent Development
10.14 Lifenet Health
10.14.1 Lifenet Health Corporation Information
10.14.2 Lifenet Health Introduction and Business Overview
10.14.3 Lifenet Health Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Lifenet Health Bio-Implants Products Offered
10.14.5 Lifenet Health Recent Development
10.15 Medtro
10.15.1 Medtro Corporation Information
10.15.2 Medtro Introduction and Business Overview
10.15.3 Medtro Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Medtro Bio-Implants Products Offered
10.15.5 Medtro Recent Development
10.16 Mimedx Group
10.16.1 Mimedx Group Corporation Information
10.16.2 Mimedx Group Introduction and Business Overview
10.16.3 Mimedx Group Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Mimedx Group Bio-Implants Products Offered
10.16.5 Mimedx Group Recent Development
10.17 Orthofix International
10.17.1 Orthofix International Corporation Information
10.17.2 Orthofix International Introduction and Business Overview
10.17.3 Orthofix International Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Orthofix International Bio-Implants Products Offered
10.17.5 Orthofix International Recent Development
10.18 Smith & Nephew
10.18.1 Smith & Nephew Corporation Information
10.18.2 Smith & Nephew Introduction and Business Overview
10.18.3 Smith & Nephew Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Smith & Nephew Bio-Implants Products Offered
10.18.5 Smith & Nephew Recent Development
10.19 Sorin
10.19.1 Sorin Corporation Information
10.19.2 Sorin Introduction and Business Overview
10.19.3 Sorin Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.19.4 Sorin Bio-Implants Products Offered
10.19.5 Sorin Recent Development
10.20 Abbott
10.20.1 Abbott Corporation Information
10.20.2 Abbott Introduction and Business Overview
10.20.3 Abbott Bio-Implants Sales, Revenue and Gross Margin (2016-2021)
10.20.4 Abbott Bio-Implants Products Offered
10.20.5 Abbott Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bio-Implants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bio-Implants Industrial Chain Analysis
11.4 Bio-Implants Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bio-Implants Distributors
12.3 Bio-Implants Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140